Attending Clinical Chemist in the Department of Laboratory Medicine at Memorial Sloan Kettering Cancer Center
BIOGRAPHY
FEB 23, 2021 8:00 AM PST
Quantitation of free light chains in serum and the need for standardization
Speaker
Event Date & Time
Date: February 23, 2021
Time: 8:00am (PST), 11:00am (EST)
Abstract
The analysis of serum free light chains (FLC) is now standard of care in the screening, diagnosis, and monitoring of patients suspected of/having multiple myeloma (MM) or other monoclonal gammopathies (MG). Recently, a new FLC immunoassay has become available from Diazyme. The objectives of our study were to analytically validate the Diazyme assay and to determine clinical interchangeability of two different FLC assays in patients with MG and in a presumed healthy population.
Learning Objectives
- Describe the serum free light chain assay and its role in the screening, diagnosis, and monitoring of patients with multiple myeloma
- List different methods by which free light chains are quantitated
- Identify issues which should be considered when switching free light chain assay
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...